About Context Therapeutics

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
2001 Market Street, Suite 3915, Unit 15, Philadelphia, Pennsylvania 19103, US
Description
Information
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company committed to advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.

Context Therapeutics Alternatives

Frequently Asked Questions about Context Therapeutics

What is Context Therapeutics email format?

The widely used Context Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.


What is Context Therapeutics customer service number?

To contact Context Therapeutics customer service number in your country click here to find.


Who is the CEO of Context Therapeutics?

Martin Lehr is the CEO of Context Therapeutics. To contact Martin Lehr email at [email protected] or [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more